Founded in 2014 and headquartered in the United States, Trefoil Therapeutics recently secured a $11.97M Venture Round investment on March 22, 2022, indicative of investor confidence in the company's regenerative therapies for corneal diseases. Despite not specifying the investors behind this recent funding, Trefoil's commitment to advancing innovative treatments in the field of ophthalmology positions it as a promising player in the biotechnology and health care industries.
Trefoil Therapeutics
Developing first-in-class investigational medicines for serious corneal diseases and disorders
Founded 2013
San Diego, United States
11 employees
Series Unknown
Total: $85.78M
Biotechnology, Health Care +1
San Diego, United States
11 employees
Series Unknown
Total: $85.78M
Biotechnology, Health Care +1
General Information
Get notified when Trefoil Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Trefoil Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Trefoil Therapeutics
Taxonomy: clinical-stage, regenerative therapies, ophthalmology, corneal diseases, investigational medicines, TTHX1114, corneal endothelial dystrophies, intracameral injection, scientific leadership, vision restoration, novel technology, biotech startups, medical research, scientific innovation
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | - | 22 Mar 2022 | |
| Series A | •••••• | 1 |
|
01 Dec 2021 |
| Venture Round | •••••• | 1 |
|
01 Jan 2020 |
| Series A | •••••• | 7 |
|
16 Jul 2019 |
| Venture Round | •••••• | 1 |
|
03 Jul 2019 |
Trefoil Therapeutics Alternatives & Competitors
Trefoil Therapeutics vs
Trefoil Therapeutics vs
EyeYon Medical
Israel
PROVIDING INNOVATIVE SOLUTIONS FOR CORNEAL HEALING, BECOMING THE FIRST CHOICE OF OPHTHALMOLOGISTS!
Series C
29 employees
Health Care, Medical Devices
Trefoil Therapeutics vs
Epion Therapeutics
United States
A clinical-stage company developing a minimally-invasive treatment for keratoconus
Series A
12 employees
Biotechnology, Health Care
FAQ About Trefoil Therapeutics
Developing first-in-class investigational medicines for serious corneal diseases and disorders
Trefoil Therapeutics was founded in 2013.
Trefoil Therapeutics is headquartered in San Diego, United States.
Trefoil Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Trefoil Therapeutics has approximately 11 employees.
Trefoil Therapeutics has completed 7 funding rounds, raising a total of $85.78M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Trefoil Therapeutics include RECORNEA, EyeYon Medical, Epion Therapeutics, Brightstar Therapeutics, Miami Eye Institute . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Trefoil Therapeutics and RECORNEA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Trefoil Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.